IMU and MaxCyte signing a supply agreement for IMU's Azer-Cel. As CHM's CEO has been and is a central figure of that IMU-Precision Bio deal I am sure that should CHM's cell supplier encounter problems MaxCyte will jump in to help out.
Securing FDA certified cell production for any kind of cell therapy is the most important factor atm, huge waiting times for those who haven't secured any.
GLTA
Ann: Investor Presentation, page-11
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $17.12M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 1.9¢ | $74.03K | 3.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1013051 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 191305 | 1 |
View Market Depth
| Last trade - 15.06pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
-0.001 ( 13.6 %) |
||||
| Open | High | Low | Volume | ||
| 2.1¢ | 2.1¢ | 1.9¢ | 2055165 | ||
| Last updated 15.45pm 29/05/2024 ? | |||||
| CHM (ASX) Chart |